Ognomy was created by board-certified sleep specialist Dr. Daniel Rifkin who directed its development as the first mobile app for the end-to-end diagnosis, testing and treatment of sleep apnea. Dr. Rifkin has more than two decades in sleep medicine practice and also founded the Sleep Medicine Centers of Western NY.

Ognomy is the first telemedicine/virtual practice tool to entirely shift the diagnosis and care of sleep apnea from a clinical setting to the home, by removing the need for overnight stays at sleep centers through home-based sleep tests and virtual consultations, saving patients both time and money. Ultimately, Ognomy removes price, logistical and social distancing barriers to diagnosing and treating this "not-so-silent killer," which affects more than 25 million Americans. As 80% of sleep apnea patients remain undiagnosed, the total addressable market is $16.9 billion USD. Patients and board-certified sleep medicine specialists use Ognomy to receive and conduct the full spectrum of sleep apnea care; ultimately paving the way for life-saving improvements in sleep and quality of life. The HIPAA-compliant app is currently available for download from the Apple App Store and Google Play.

Ognomy was one of 12 finalists in the Global Wellness Summit's 2020 Wellness Innovation contest. More than 900 patients have been served through the app. Headquartered in Buffalo, N.Y., the app is currently operational in New York, Florida and Georgia, with the goal of expanding to 23 states in 2021, scaling up to be available throughout the United States with its first international market by 2022. Visit www.ognomy.com for more information.